World News
-
GSK to advance genomic research and improve drug discovery
World | News | 0 Comment | 14 Jun, 2019
GlaxoSmithKline plc has announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics...Read more
-
Novartis continues to innovate in CML
World | News | 0 Comment | 14 Jun, 2019
Long-term follow-up data from the ongoing, pivotal open-label ENESTfreedom and ENESTop trials showed sustained treatment-free remission (TFR) after stopping frontline and second-line Tasign...Read more
-
BlackStone Therapeutics closes $76 m Series B financing
World | News | 0 Comment | 14 Jun, 2019
BlackThorn Therapeutics, a clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, today announ...Read more
-
AllMed Healthcare Management joins fight to end opioid epidemic
World | News | 0 Comment | 14 Jun, 2019
AllMed Healthcare Management has announced a corporate initiative designed to increase coverage of and access to evidence-based addiction treatment. A cornerstone of the initiative is a par...Read more
-
World | News | 0 Comment | 14 Jun, 2019
Dr. Reddy’s Laboratories Limited has announced that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories pursuant to which Dr. Redd...Read more
-
IBM, KPMG, Merck and Walmart to evaluate the use of blockchain in pharma
World | News | 0 Comment | 14 Jun, 2019
IBM, KPMG, Merck and Walmart has announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U.S. D...Read more
-
Thomas Schinecker appointed as CEO of Roche Diagnostics
World | News | 0 Comment | 13 Jun, 2019
Roche has announced that Peter Voser (61), a member of the Board of Directors of Roche Holding Ltd since 2011, has decided to step down as a member of the Board of Directors of Roche a...Read more
-
Merck buys Tilos Therapeutics in a $773M deal
World | News | 0 Comment | 13 Jun, 2019
Merck known as MSD outside the United States and Canada has announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical compa...Read more
-
Dulaglutide reduces cardiovascular disease in Type-2 diabetic people
World | News | 0 Comment | 10 Jun, 2019
The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 (GLP-1) receptor agonist, dem...Read more
-
Thermo Fisher Scientific acquires HighChem
World | News | 0 Comment | 10 Jun, 2019
Thermo Fisher Scientific, the world leader in serving science has recently announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry softwa...Read more
-
Thermo Scientific launches Rheometer series for quality control labs
World | News | 0 Comment | 10 Jun, 2019
The Thermo Scientific HAAKE MARS iQ Rheometer was specifically designed to meet the needs of QC labs with built-in features that assist users to deliver more reliable results. Key features ...Read more
-
Labcorp, QIAGEN announce companion diagnostic for metastatic breast cancer
World | News | 0 Comment | 11 Jun, 2019
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care has announced a new companion diagnostic called therascreen PIK3CA PCR...Read more
-
PTC gets FDA nod for the expansion of the EMFLAZA® labeling
World | News | 0 Comment | 10 Jun, 2019
PTC Therapeutics is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits ...Read more
-
FDA approves new treatment for hospital acquired infections
World | News | 0 Comment | 10 Jun, 2019
The U.S. Food and Drug Administration has approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacteri...Read more
-
First patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
World | News | 0 Comment | 07 Jun, 2019
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, announced on 4 June 2019, that the first patient has been dosed with its lead candidate, le...Read more
-
FSD Pharma adds two more prominent Cannabis researchers to Scientific Advisory Board
World | News | 0 Comment | 07 Jun, 2019
FSD Pharma Inc. has announced the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board. “It is with great pride tha...Read more
-
PhoenixMD and WuXi STA to Support Phase I/Ib Study of PMD-026 for TNBC
World | News | 0 Comment | 07 Jun, 2019
Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics targeting essential kinases, announces the completion of clinical trial s...Read more
-
DuPont Microbiome announces a strategic partnership with BioMe Oxford
World | News | 0 Comment | 07 Jun, 2019
The DuPont Microbiome Venture announces a strategic investment and partnership with BioMe Oxford Ltd. BioMe Oxford is an early stage startup located in Oxford, United Kingdom, which is deve...Read more
